Find uplifting stories about heroes, innovations, and solutions
8887 results for "narcolepsy treatment"
A groundbreaking treatment just approved by the FDA is giving people with narcolepsy their lives back, targeting the disease's root cause for the first time. Up to 84% of patients achieved normal sleepiness levels in major trials.
People with narcolepsy now have a breakthrough treatment option after the FDA approved a first-of-its-kind drug for the sleep disorder. The new medication offers hope to thousands who struggle with overwhelming daytime sleepiness.
Scientists are developing a promising new treatment for narcolepsy, a chronic disorder that makes staying awake a daily battle for millions worldwide. The breakthrough could transform life for people who struggle with uncontrollable sleep episodes.
China just approved the world's first medication that targets the biological cause of narcolepsy, not just its symptoms. The breakthrough treatment could help millions who experience sudden muscle weakness and overwhelming daytime sleepiness.
People with narcolepsy just got their first truly effective treatment option. The FDA approved Orzeyful, a groundbreaking pill that helps patients stay awake far longer than existing medications.
UK researchers found that tocilizumab, a common arthritis medication, helped people with depression who didn't respond to standard antidepressants. The breakthrough could offer hope to millions struggling with treatment-resistant depression.
A new UCLA study shows an intensive five-day magnetic brain stimulation protocol works as well as the traditional six-week treatment for depression. This breakthrough could help thousands of patients who struggle to commit to months of clinic visits.
Four promising new treatments could reach patients this spring, offering fresh hope for people battling hard-to-treat conditions. From the first-ever medication for a chronic liver infection to an at-home Alzheimer's treatment, these therapies represent real progress for patients who've been waiting.
%2Fhttps%3A%2F%2Ftf-cmsv2-smithsonianmag-media.s3.amazonaws.com%2Ffiler_public%2F47%2Ffc%2F47fc814d-c7fd-46ae-b4d2-5f8be614e012%2Fnarcolepsy.jpg)
The FDA just approved Orzeyful, the first medication that treats the underlying cause of narcolepsy type 1 instead of just masking symptoms. For 120,000 Americans living with extreme daytime sleepiness and sudden muscle weakness, this breakthrough could transform daily life.
Federal regulators just approved a groundbreaking melanoma treatment that transforms the herpes virus into a cancer-fighting weapon. For patients whose advanced skin cancer stopped responding to standard treatments, this innovative therapy offers new hope.
A Shanghai neurologist discovered a potential Alzheimer's therapy after his 90-year-old mother improved cognitively following ultrasound treatment for a different condition. His trial now tests high-intensity focused ultrasound as a standalone treatment, a promising departure from mainstream research.
After 20 years of research, the FDA approved Orzeyful, the first drug that replaces the missing brain chemical causing narcolepsy in 120,000 Americans. Patients who could barely stay awake five minutes now maintain alertness for over 20 minutes, with some taking up hobbies for the first time. #
A new HIV pill taken just once a week appears as effective as daily treatment in major studies. Over six million South Africans currently on daily HIV medication could benefit from simpler treatment.
A groundbreaking study will use advanced imaging to personalize cancer treatment, potentially cutting unnecessary therapy while helping more patients access care. The collaboration could transform how doctors decide when prostate cancer patients have received enough treatment.
For the first time in decades, Americans with treatment-resistant depression have two powerful new options that work differently than anything before. Clinical trials show these breakthrough treatments are helping patients who've struggled for years finally find relief.
People newly diagnosed with multiple sclerosis who started B-cell therapy early had 62% fewer relapses than those on standard oral treatments. This breakthrough study gives doctors and patients clearer guidance on which treatments work best right from the start.
UK scientists created a simple blood test that tells doctors whether breast cancer treatment will work before therapy even begins. The breakthrough could spare patients from months of ineffective drugs and help them find treatments that actually work.
Bladder cancer patients now have access to breakthrough treatments that are improving survival rates and reducing recovery times. From robot-assisted surgery to personalized medicine, new advances are transforming what was once a limited treatment landscape into a field full of hope.
Patients with chronic lymphocytic leukemia now have a new treatment option that doesn't require chemotherapy and allows time off from treatment. The FDA approved the first all-oral, fixed-duration therapy for this common adult leukemia.
Scientists have enrolled the first patient in a groundbreaking trial to find effective treatments for the deadly Bundibugyo strain of Ebola in the Democratic Republic of Congo. The trial brings hope to a region where more than 1,400 people have been infected since May, with currently no approved treatments available.
Showing 20 of 8887